Search Results - "Verhezen, Paul W.M."

Platelet Aggregation in Healthy Participants is Not Affected by Smoking, Drinking Coffee, Consuming a High-Fat Meal, or Performing Physical Exercise by Krekels, Joyce P.M., Verhezen, Paul W.M., Henskens, Yvonne M.C.

“…Platelet aggregation can be measured using optical aggregation (light transmission aggregometry, LTA) as well as by impedance (Multiplate analyzer). The LTA…”
Get full text

Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO by Streng, Alexander S, Delnoij, Thijs S R, Mulder, Mark M G, Sels, Jan Willem E M, Wetzels, Rick J H, Verhezen, Paul W M, Olie, Renske H, Kooman, Jeroen P, van Kuijk, Sander M J, Brandts, Lloyd, Ten Cate, Hugo, Lorusso, Roberto, van der Horst, Iwan C C, van Bussel, Bas C T, Henskens, Yvonne M C

“…Severe cases of coronavirus disease 2019 (COVID-19) can require continuous renal replacement therapy (CRRT) and/or extracorporeal membrane oxygenation (ECMO)…”
Get full text

Effectiveness and costs of a stepwise versus an all‐in‐one approach to diagnose mild bleeding disorders by Heubel‐Moenen, Floor C. J. I., Ansems, Loes E. M., Verhezen, Paul W. M., Wetzels, Rick J. H., Oerle, Rene G. M., Straat, Ron J. M. H. E., Megy, Karyn, Downes, Kate, Henskens, Yvonne M. C., Beckers, Erik A. M., Joore, Manuela A.

“…Summary The diagnostic work‐up of patients referred to the haematologist for bleeding evaluation is performed in a stepwise way: bleeding history and results…”
Get full text

Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time by Heubel‐Moenen, Floor C. J. I., Brouns, Sanne L. N., Herfs, Linda, Boerenkamp, Lara S., Jooss, Natalie J., Wetzels, Rick J. H., Verhezen, Paul W. M., Machiels, Patric, Megy, Karyn, Downes, Kate, Heemskerk, Johan W. M., Beckers, Erik A. M., Henskens, Yvonne M. C.

“…Summary Patients referred for evaluation of bleeding symptoms occasionally have a prolonged platelet function analyser (PFA) closure time, without evidence for…”
Get full text

Screening for platelet function disorders with Multiplate and platelet function analyzer by Moenen, Floor C. J. I., Vries, Minka J. A., Nelemans, Patricia J., van Rooy, Katrien J. M., Vranken, Jeannique R. R. A., Verhezen, Paul W. M., Wetzels, Rick J. H., ten Cate, Hugo, Schouten, Harry C., Beckers, Erik A. M., Henskens, Yvonne M. C.

“…Light transmission aggregation (LTA) is the gold standard for the diagnosis of platelet function disorders (PFDs), but it is time-consuming and limited to…”
Get full text

Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study by Post, Demi S, van der Veer, Arian, Schijns, Olaf E M G, Klinkenberg, Sylvia, Rijkers, Kim, Wagner, G Louis, van Kranen-Mastenbroek, Vivianne H J M, Willems, Paul C P H, Verhezen, Paul W M, Beckers, Erik A M, Heubel-Moenen, Floor C J I, Henskens, Yvonne M C

“…Valproic acid (VPA) is a frequently prescribed anti-epileptic drug. Since its introduction side effects on hemostasis are reported. However, studies show…”
Get full text

Fibrinolysis in patients with chemotherapy‐induced thrombocytopenia and the effect of platelet transfusion by Heubel‐Moenen, Floor C. J. I., Henskens, Yvonne M. C., Verhezen, Paul W. M., Wetzels, Rick J. H., Schouten, Harry C., Beckers, Erik A. M.

“…Essentials Bleeding in chemotherapy induced thrombocytopenia (CIT) might be influenced by hyperfibrinolysis. t‐PA‐thromboelastography is a fast and reliable…”
Get full text

Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms by Vries, Minka J.A., Macrae, Fraser, Nelemans, Patricia J., Kuiper, Gerhardus J.A.J.M., Wetzels, Rick J.H., Bowman, Polly, Verhezen, Paul W.M., ten Cate, Hugo, Ariëns, Robert A.S., Henskens, Yvonne M.C.

“…Enhanced clot lysis is associated with bleeding, but assessment of lysis capacity remains difficult. The plasma turbidity lysis and whole blood tissue…”
Get full text

The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function by Kuiper, Gerhardus J. A. J. M., Houben, Rik, Wetzels, Rick J. H., Verhezen, Paul W. M., Oerle, Rene van, ten Cate, Hugo, Henskens, Yvonne M. C., Lancé, Marcus D.

“…Low platelet counts and hematocrit levels hinder whole blood point-of-care testing of platelet function. Thus far, no reference ranges for MEA (multiple…”
Get full text

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention by Hulshof, Anne-Marije, Olie, Renske H, Vries, Minka J A, Verhezen, Paul W M, van der Meijden, Paola E J, Ten Cate, Hugo, Henskens, Yvonne M C

“…Patients using antithrombotic drugs after percutaneous coronary intervention (PCI) are at risk for bleeding and recurrent ischemia. We aimed to explore routine…”
Get full text

Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients by Vries, Minka J.A., Bouman, Heleen J., Olie, Renske H., Veenstra, Leo F., Zwaveling, Suzanne, Verhezen, Paul W.M., ten Cate-Hoek, Arina J., ten Cate, Hugo, Henskens, Yvonne M.C., van der Meijden, Paola E.J.

“…Aims Therapeutic windows for residual platelet reactivity in patients with coronary artery disease on P2Y12 inhibitors were proposed in a consensus document…”
Get full text